Mode
Text Size
Log in / Sign up

Functional Coronary Angiography Improves Clinical Outcomes in Multivessel STEMI PatientsPhysiology guided heart procedures show lower risk of major events

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Physiology-guided revascularization significantly reduces major adverse events and improves safety in multivessel STEMI.

The management of patients presenting with ST-segment elevation myocardial infarction (STEMI) and multivessel disease requires precise decision-making regarding the extent and location of revascularization. This randomized trial evaluated the efficacy of utilizing functional coronary angiography to guide complete revascularization versus the standard of care, which relies on conventional angiography. The study enrolled 1,823 patients who had already undergone successful treatment of the culprit lesion, providing a robust sample size to assess the impact of physiological assessment on long-term outcomes.

In the intervention arm, clinicians utilized functional coronary angiography to determine the optimal targets for complete revascularization. This approach aims to identify and treat lesions that significantly contribute to myocardial ischemia, rather than treating all significant-looking stenoses. The comparator group received treatment guided solely by conventional angiography, which relies on visual luminal narrowing. The primary endpoint was a composite of death, myocardial infarction, cerebrovascular accident, or the need for ischemia-driven revascularization within a 17.9-month follow-up period.

Results demonstrated a statistically significant reduction in the primary composite endpoint for the physiology-guided cohort. Specifically, the event rate was 8.9% in the intervention group compared to 13.7% in the angiography-guided group. The hazard ratio was 0.62 (95% CI, 0.47, 0.83; P<0.001), indicating a substantial decrease in major adverse events when functional data informed the revascularization strategy. This suggests that physiological assessment helps clinicians prioritize lesions that have the greatest impact on myocardial perfusion.

Safety outcomes were also favorable in the physiology-guided group. The primary safety outcome, a composite of contrast-associated acute kidney injury or major bleeding, occurred in 4.6% of patients in the intervention arm versus 7.1% in the angiography-guided arm. The hazard ratio for these adverse events was 0.63 (95% CI, 0.43 to 0.93; P=0.02). This indicates that a physiology-driven approach may not only improve clinical outcomes but also potentially improve the safety profile by potentially reducing the number of unnecessary interventions. From a clinical perspective, these findings suggest that integrating functional coronary angiography into the workflow for multivessel STEMI patients provides a superior roadmap for treatment. By identifying lesions that are truly hemodynamically significant, clinicians can optimize the revascularization strategy, leading to fewer complications and better long-term patient outcomes. The significant reduction in ischemia-driven revascularization suggests that the initial physiology-guided intervention was more effective at addressing the underlying pathology. In conclusion, the integration of functional coronary angiography into the management of multivessel STEMI provides a clear advantage over conventional angiography. The data support a shift toward physiology-guided strategies to improve safety and efficacy. This evidence-based approach allows for more precise targeting of ischemic tissue, ultimately reducing the risk of major cardiovascular events and complications in a high-risk patient population.

How this fits prior evidence

How this fits prior evidence This finding addresses a gap in the management of multivessel disease following STEMI by providing a specific comparison between physiology-guided and angiography-guided revascularization. While prior evidence has focused on pharmacological interventions like ticagrelor monotherapy to reduce bleeding, high-dose statin preloading to improve reperfusion, and pressure optimization protocols to reduce postdilation, this study specifically addresses the procedural guidance strategy for multivessel disease. It provides a new evidence base for the role of functional coronary angiography in improving outcomes and safety in this specific patient population.

Heart disease is a serious condition that affects millions of people worldwide. For those who experience a heart attack, especially those with complex blockages in multiple arteries, the way doctors decide which vessels to treat is a critical decision. This research looks at how different methods of guiding these procedures might affect long-term safety and health for patients who have already had their main blockage treated but still have other significant issues in their heart's blood supply.

The study involved a large group of 1,823 patients who had suffered from a specific type of heart attack called a STEMI. These patients also had multivessel disease, meaning several of their heart arteries were blocked. The researchers divided these patients into two groups. One group received treatment guided by conventional angiography, which is the standard way of looking at the heart's blood vessels. The other group received treatment guided by functional coronary angiography. This method uses extra tools to measure how well blood flows through the arteries to help doctors decide which ones need treatment.

The results of the trial showed a significant difference in outcomes over a period of about 18 months. In the group where doctors used functional imaging to guide their decisions, the rate of major complications was lower. Specifically, the primary outcome—which included death, another heart attack, a stroke, or the need for more procedures—was 8.9% in the group guided by physiology. In contrast, the rate was 13.7% in the group guided by conventional methods. This suggests that using functional data to guide the procedure may help reduce the risk of these serious medical events.

Safety was also monitored closely during the trial. The researchers looked at risks like kidney damage from the procedure's contrast dye or major bleeding. The study found that these safety issues occurred less often in the group that used the physiology-guided approach. Specifically, the rate of these safety issues was 4.6% in the physiology-guided group compared to 7.1% in the conventional group. While these numbers are lower in the guided group, it is important to note that both groups were monitored for safety throughout the study.

It is important to remember that while these results are promising, this is one study and does not change everything immediately. The study was international and involved a large number of people, which gives the findings some weight, but individual results can vary based on a person's specific health history. Doctors will continue to use these findings to help decide the best path forward for patients with complex heart conditions. For now, this research provides a helpful tool for doctors to consider when planning how to treat multiple blocked arteries after a heart attack.

What this means for you:
Physiology-guided heart procedures showed a lower risk of stroke and heart attack compared to standard methods.

Study Details

Study typeRct
Sample sizen = 1,823
EvidenceLevel 2
Follow-up792.0 mo
PublishedSep 2026
View Original Abstract ↓
BACKGROUND: Complete coronary-artery revascularization is recommended in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, but the preferred strategy for identifying nonculprit lesions that warrant treatment remains uncertain. METHODS: In this international, randomized trial, we assigned patients with STEMI and multivessel disease in whom the culprit lesion had been successfully treated to undergo complete coronary-artery revascularization guided by functional coronary angiography (physiology-guided group) or by conventional angiography (angiography-guided group). The primary outcome was a composite of death from any cause, myocardial infarction, cerebrovascular accident (stroke or transient ischemic attack), or ischemia-driven revascularization, assessed in a time-to-event analysis. The primary safety outcome was a composite of contrast-associated acute kidney injury or major bleeding. RESULTS: A total of 1823 patients underwent randomization; 913 were assigned to the physiology-guided group and 910 assigned to the angiography-guided group. The median age of the patients was 66 years (interquartile range, 58 to 76), and 24% were women. At a median follow-up of 17.9 months, a primary-outcome event had occurred in 81 patients (8.9%) in the physiology-guided group and in 125 patients (13.7%) in the angiography-guided group (hazard ratio, 0.62; 95% confidence interval [CI], 0.47 to 0.83; P<0.001). A primary-safety-outcome event occurred in 42 patients (4.6%) in the physiology-guided group and in 65 patients (7.1%) in the angiography-guided group (hazard ratio, 0.63; 95% CI, 0.43 to 0.93; P = 0.02). CONCLUSIONS: In patients with STEMI and multivessel coronary artery disease, a strategy of complete coronary-artery revascularization guided by functional coronary angiography resulted in a lower risk of a primary-outcome event (death, myocardial infarction, cerebrovascular accident, or ischemia-driven revascularization) than a strategy guided by conventional angiography. (Funded by the Italian Health Ministry and others; AIR-STEMI ClinicalTrials.gov number, NCT05818475.).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.